C4X Discovery Holdings (C4XD)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.23p
   
  • Change Today:
    -0.33p
  • 52 Week High: 21.45
  • 52 Week Low: 7.40
  • Currency: UK Pounds
  • Shares Issued: 252.23m
  • Volume: 1,024,803
  • Market Cap: £20.75m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Jan-24 Interim 24.65 17.80 7.06p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jul-19 n/a (13.62) (18.60)p n/a n/a n/a n/a 0.0%
31-Jul-20 n/a (9.58) (8.10)p n/a n/a n/a n/a 0.0%
31-Jul-21 5.64 (5.91) (1.96)p n/a n/a n/a n/a 0.0%
31-Jul-22 2.70 (10.53) (3.57)p n/a n/a n/a n/a 0.0%
31-Jul-23 1.71 (13.42) (4.42)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Jul-24 30.20 14.65 6.90p 1.2 n/a n/a n/a 0.0%
31-Jul-25 6.00 (9.90) (2.80)p n/a n/a n/a n/a 0.0%
31-Jul-26 8.10 (8.20) (2.10)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

C4XD Market Data

Currency UK Pounds
Share Price 8.23p
Change Today -0.33p
% Change -3.80 %
52 Week High 21.45
52 Week Low 7.40
Volume 1,024,803
Shares Issued 252.23m
Market Cap £20.75m

C4XD Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.06% above the market average36.06% above the market average36.06% above the market average36.06% above the market average36.06% above the market average
1.89% below the sector average1.89% below the sector average1.89% below the sector average1.89% below the sector average1.89% below the sector average
Price Trend
82.81% below the market average82.81% below the market average82.81% below the market average82.81% below the market average82.81% below the market average
29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average29.82% below the sector average
Income Not Available
Growth
46.95% below the market average46.95% below the market average46.95% below the market average46.95% below the market average46.95% below the market average
72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average72.97% below the sector average

What The Brokers Say

Strong Buy 0
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

C4XD Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
16:36 75,000 @ 8.25p
16:29 10,114 @ 8.08p
15:41 12,854 @ 8.08p
15:17 5,000 @ 8.40p
15:16 308 @ 8.00p

C4XD Key Personnel

CEO Clive Dix
CFO Bradley Hoy

Top of Page